196 related articles for article (PubMed ID: 24608647)
21. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
22. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis.
Dähnhardt-Pfeiffer S; Dähnhardt D; Buchner M; Walter K; Proksch E; Fölster-Holst R
J Dtsch Dermatol Ges; 2013 May; 11(5):437-43. PubMed ID: 23551950
[TBL] [Abstract][Full Text] [Related]
23. Tacrolimus ointment for the management of atopic dermatitis.
Rustin M
Hosp Med; 2003 Apr; 64(4):214-7. PubMed ID: 12731133
[TBL] [Abstract][Full Text] [Related]
24. Molluscum contagiosum in atopic dermatitis treated with 0.1% tacrolimus ointment.
Wilson LM; Reid CM
Australas J Dermatol; 2004 Aug; 45(3):184-5. PubMed ID: 15250900
[TBL] [Abstract][Full Text] [Related]
25. Eczema herpeticum during treatment of atopic dermatitis with 1% pimecrolimus cream.
Segura S; Romero D; Carrera C; Iranzo P; Estrach T
Acta Derm Venereol; 2005; 85(6):524-5. PubMed ID: 16396803
[No Abstract] [Full Text] [Related]
26. Quality Testing of Tacrolimus Ointment Mixed with Various Type of Ointments or Creams.
Nakane T; Doi H; Hirohara M; Hamashima H; Inoue Y
Biol Pharm Bull; 2018; 41(11):1632-1637. PubMed ID: 30381662
[TBL] [Abstract][Full Text] [Related]
27. Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis.
Hebert AA; Koo J; Fowler J; Berman B; Rosenberg C; Levitt J
Cutis; 2006 Nov; 78(5):357-63. PubMed ID: 17186796
[TBL] [Abstract][Full Text] [Related]
28. A treatment approach for atopic dermatitis.
Dohil MA; Eichenfield LF
Pediatr Ann; 2005 Mar; 34(3):201-10. PubMed ID: 15792112
[No Abstract] [Full Text] [Related]
29. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
[TBL] [Abstract][Full Text] [Related]
30. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.
Eichenfield LF; Tom WL; Berger TG; Krol A; Paller AS; Schwarzenberger K; Bergman JN; Chamlin SL; Cohen DE; Cooper KD; Cordoro KM; Davis DM; Feldman SR; Hanifin JM; Margolis DJ; Silverman RA; Simpson EL; Williams HC; Elmets CA; Block J; Harrod CG; Smith Begolka W; Sidbury R
J Am Acad Dermatol; 2014 Jul; 71(1):116-32. PubMed ID: 24813302
[TBL] [Abstract][Full Text] [Related]
31. [Tacrolimus ointment for the treatment of atopic dermatitis].
Ohtsuki M
Arerugi; 2009 May; 58(5):499-506. PubMed ID: 19487830
[No Abstract] [Full Text] [Related]
32. Topical treatment of atopic dermatitis.
Boguniewicz M
Immunol Allergy Clin North Am; 2004 Nov; 24(4):631-44, vi-vii. PubMed ID: 15474863
[TBL] [Abstract][Full Text] [Related]
33. How should we care for atopic dermatitis?
Holten KB;
J Fam Pract; 2005 May; 54(5):426-7. PubMed ID: 15865900
[No Abstract] [Full Text] [Related]
34. Reduction of serum TARC levels in atopic dermatitis by topical anti-inflammatory treatments.
Yasukochi Y; Nakahara T; Abe T; Kido-Nakahara M; Kohda F; Takeuchi S; Hagihara A; Furue M
Asian Pac J Allergy Immunol; 2014 Sep; 32(3):240-5. PubMed ID: 25268342
[TBL] [Abstract][Full Text] [Related]
35. Pediatric atopic dermatitis: a review of the medical management.
Carbone A; Siu A; Patel R
Ann Pharmacother; 2010 Sep; 44(9):1448-58. PubMed ID: 20628042
[TBL] [Abstract][Full Text] [Related]
36. [New immune suppressants: topical immunomodulatory agents].
Senatorski G; Sułowicz W; Paczek L
Przegl Lek; 2002; 59(11):907-11. PubMed ID: 12715720
[TBL] [Abstract][Full Text] [Related]
37. [Viewpoint of the German Dermatologic Society (DDG) concerning the decision of the American Food and Drug Administration (FDA) on the use of pimecrolimus cream and tacrolimus ointment in the treatment of atopic dermatitis (neurodermatitis)].
Luger TA; Gollnick H
J Dtsch Dermatol Ges; 2005 Jun; 3(6):415-6. PubMed ID: 15892843
[No Abstract] [Full Text] [Related]
38. [Oral therapy for atopic dermatitis in year 2000. Questionnaire Study to Boarding Members of Japanese Society for Allergology].
Aoki T; Kono T
Arerugi; 2003 Apr; 52(4):434-43. PubMed ID: 12754420
[TBL] [Abstract][Full Text] [Related]
39. Topical tacrolimus: a new therapy for atopic dermatitis.
Russell JJ
Am Fam Physician; 2002 Nov; 66(10):1899-902. PubMed ID: 12469964
[TBL] [Abstract][Full Text] [Related]
40. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
